相关实验视频
Updated: Sep 10, 2025

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.7K
对胃炎症状的雷巴米皮德的实际有效性:以患者为中心的方法
Hyun Ji Woo1,2, Tae-Kyu Kwon3, Seol Ju Moon4,5,6,7
1Department of Healthcare Engineering, Graduate School, Jeonbuk National University, Jeonju, Republic of Korea.
Clinical and translational science
|August 23, 2025
概括
雷巴米皮德单一治疗有效缓解胃炎症状,与实践中使用质子抑制剂 (PPI) 的联合治疗结果相似. 这表明雷巴米皮德单一治疗是治疗胃肠道不适的可行选择.
科学领域:
- 胃肠病学
- 药理学
- 临床研究
背景情况:
- 胃粘膜保护剂如雷巴米皮德对于治疗胃炎症状至关重要.
- 仅有有限的实验数据比较单独使用雷巴米皮德与包括质子抑制剂 (PPI) 在内的联合治疗.
研究的目的:
- 在现实临床环境中评估雷巴米皮德单一治疗与PPI联合治疗在减轻主观胃肠道 (GI) 症状方面的比较有效性.
- 评估患者报告的胃炎症状缓解的结果.
主要方法:
- 一项多中心的观察性研究涉及2209名19岁以上的患者,他们接受了治疗胃炎的雷巴米皮德.
- 患者接受了二至六周的雷巴米皮德治疗,通过患者报告的结果来评估胃肠道症状的严重程度和频率.
- 使用逆治疗概率 (IPTW) 来调整基线混,比较单一治疗和组合治疗组.
主要成果:
- 无论是单独治疗还是联合治疗,都显著降低了治疗后的胃肠道症状得分.
- 在IPTW后,症状严重程度,频率或总得分之间没有显著差异.
- 症状改善率 (≥50% 减少) 类似:单一治疗为71. 5%,组合治疗为71. 4% (p=0. 976).
结论:
- 在常规的临床实践中,雷巴米皮德单一疗法在缓解胃炎症状方面表现出与PPI联合疗法相当的有效性.
- 这些发现支持rebamipide作为胃炎症状患者的有效治疗选择.
相关概念视频
Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
Gastritis III: Clinical Manifestations and Management
474
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
474
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569
Gastroesophageal Reflux Disease II: Clinical Features and Management
199
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
199
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189

